Cell Therapy Market by Product Type, Distribution Channel, End User 2023-2028

Author: Elena Anderson, Marketing Manager |

Report DescriptionAbout IMARC Group

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description Report Description and Highlights

Global Cell Therapy Market Research Report:

The latest report by IMARC, titled “ Cell Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-202

8

” the global cell therapy market size reached US$ 11.5 Billion in 2022.

Cell therapy (CT) replaces or repairs damaged tissues and cells by using human cells as transplants. This technology is used to develop and apply new techniques to restore function and heal tissues and organs inflicted by aging, disease, and damage.

The therapy also improves the immune system of the body to combat cancer cells. Cell therapy can also be used to treat numerous autoimmune and infectious diseases, urinary problems, joint damage, spinal cord injuries, weakened immune systems, and neurological disorders.

Request Free Sample Report: https://www.imarcgroup.com/cell-therapy-market/requestsample

Global Cell Therapy Market Trends:

The global market is majorly driven by the rising incidences of numerous chronic diseases, including cancer and cardiovascular disorders. In line with this, the increasing promotions of clinical trials by various governing agencies of several countries are contributing to the growth of the market. Moreover, the extensive research and development (R&D) activities conducted by key players regarding stem cell therapy are providing an impetus to the market. In addition to this, the introduction of advanced cell-based therapies, such as direct cell reprogramming for neuronal tissue replacement, skin rejuvenation and tendon regeneration therapies, is creating a positive market outlook.

Furthermore, continual technological advancements in the healthcare infrastructure are acting as another significant growth-inducing factor. Some of the other factors contributing to the market growth include the escalating demand for regenerative drugs and a considerable increase in medical expenditure. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 32.1 Billion by 2028, exhibiting a CAGR of 17.5% during 2023-2028.

Report Description Report Description and Highlights

Market Summary:

Breakup by Cell Type:

• Stem Cell

• Bone Marrow

• Blood

• Umbilical Cord-Derived

• Adipose-Derived Stem Cell

• Others

• Non-stem Cell

Breakup by Therapy Type:

• Autologous

• Allogeneic

Breakup by Therapeutic Area:

• Malignancies

• Musculoskeletal Disorders

• Autoimmune Disorders

• Dermatology

• Others

Breakup by End User:

• Hospitals and Clinics

• Academic and Research Institutes

Breakup by Region:

• North America

• United States

• Canada

• Asia-Pacific

• China

• Japan

• India

• South Korea

• Australia

• Indonesia

• Others

• Europe

• Germany

• France

• United Kingdom

• Italy

• Spain

• Russia

• Others

• Latin America

• Brazil

• Mexico

• Others

• Middle East and Africa

Competitive Landscape with Key Players:

• AlloSource

• Anterogen Co. Ltd.

• Cells for Cells

• Holostem Terapie Avanzate S.r.l.

• JCR Pharmaceuticals

• Kolon TissueGene Inc.

• MEDIPOST

• Mesoblast Limited

• NuVasive

• Stemedica Cell Technologies Inc.

• Stempeutics Research Pvt. Ltd

• Vericel Corporation

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/cell-therapy-market

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

Report Description Report Description and Highlights

© 2019 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.